{
  "LinkTitle": "D-2022-1730",
  "Status": "Intermediate",
  "InitialDMPReviewStatus": "Reviewed",
  "Funder": "BOF",
  "ProjectTitle": "Glial-immune interactions in the gastrointestinal tract: protection against inflammation and cancer",
  "InitialFeedbackHistory": "31/05/2023 [REDACTED] please also list the cells and/or samples that you will use, these are physical data, do these need special management such as storage under specific conditions? [REDACTED] your ethical approval numbers are already a bit older, please ensure that they are still valid or apply for a renewal. https://research.kuleuven.be/en/associatienet/ethics/index [REDACTED] the metadata links you give are not the most suitable for your data, I don't see proteomics in your table and the standard for genomics that you give is for pathogens. [REDACTED] sequencing MINSEQE is often used, check in the repository where you reuse data or ask the sequencing facility. [REDACTED] flow cytometry MIFlowCyt is widely used and for IHC OME. [REDACTED] more information: www.kuleuven.be/rdm/en/guidance/documentation-metadata [REDACTED] [REDACTED] ensure compliance with GDRP, please use [REDACTED] repositories such as RDR (https://www.kuleuven.be/rdm/en/rdr) or EGA (https://ega-archive.org/) and restrict access for data from human tissue, contact the data access committee (dac@uzleuven.be) before depositing",
  "label": "good with suggestions"
}